APPYEA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0218 USD | -1.82% |
|
-39.94% | +45.33% |
| 01/04 | AppYea, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 20/03 | AppYea, Inc. Launches E-Commerce Store on Amazon Broadening Distribution | CI |
| Sales 2022 | - | Sales 2023 | - | Capitalization | 4.93M 411M |
|---|---|---|---|---|---|
| Net income 2022 | -1M -83.42M | Net income 2023 | -1M -83.42M | EV / Sales 2022 | - |
| Net Debt 2022 | 2.28M 190M | Net Debt 2023 | 1.86M 155M | EV / Sales 2023 | - |
| P/E ratio 2022 |
-7.24
x | P/E ratio 2023 |
-2.12
x | Employees | 9 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 57.67% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.82% | ||
| 1 week | -39.94% | ||
| Current month | -31.88% | ||
| 1 month | -33.94% | ||
| 3 months | +9.00% | ||
| 6 months | -20.73% | ||
| Current year | +45.33% |
1 week
0.02
0.03
1 month
0.020.04
Current year
0.010.17
1 year
0.000.17
3 years
0.000.17
5 years
0.000.17
10 years
0.000.17
| Managers | Title | Age | Since |
|---|---|---|---|
Adi Shemer
CEO | Chief Executive Officer | 52 | 07/23/07 |
Boris Molchadsky
CHM | Chairman | 47 | - |
Asaf Porat
DFI | Director of Finance/CFO | 46 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Asaf Porat
DFI | Director of Finance/CFO | 46 | - |
Ron Mekler
BRD | Director/Board Member | 51 | 23/23/23 |
Boris Molchadsky
CHM | Chairman | 47 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/24/01 | 0.0218 | -1.82% | 57,523 |
| 30/24/30 | 0.0222 | -0.45% | 31,602 |
| 29/24/29 | 0.0223 | -17.53% | 34,300 |
| 26/24/26 | 0.027 | 0.00% | 4,530 |
| 25/24/25 | 0.027 | +12.67% | 1,631 |
Delayed Quote OTC Markets, May 02, 2024 at 12:42 am IST
More quotes
AppYea, Inc. is a digital health company, which is focused on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring and fundamentally improve quality of life. The Companyâs business plan focuses on two principal devices and an App in development: DreamIT and DreamIT PRO, and SleepX PRO. DreamIT is a biofeedback snoring treatment wristband, combined with the SleepX App and this wristband uses algorithms designed by SleepX combined with sensors to monitor physiological parameters during sleep. DreamIT PRO is a wristband for the treatment of sleep apnea using biofeedback in combination with the SleepX PRO app. The algorithms of SleepX PRO, combined with the wristband sensors, monitor sleep apnea events and additional physiological parameters during sleep, and when necessary. SleepX PRO is a medical application that is used to monitor breathing patterns in sleep and identify sleep apnea episodes without direct contact with the user.
Sector
Software
| 1st Jan change | Capi. | |
|---|---|---|
| +45.33% | 9.83M | |
| -4.61% | 26.03B | |
| +29.62% | 23.78B | |
| +9.49% | 2.62B | |
| -18.22% | 1.96B | |
| +92.99% | 1.95B | |
| -55.59% | 1.47B | |
| +16.47% | 1.47B | |
| -15.67% | 1.29B | |
| +3.27% | 1.27B |
- Stock Market
- Equities
- APYP Stock
